Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 155,088 | 104,953 | 293,477 | 394,553 | 485,680 |
| Marketable Securities | 913,580 | 852,569 | 571,930 | 644,622 | 823,251 |
| Receivables | N/A | N/A | N/A | N/A | 15,218 |
| Other current assets | 357 | 0 | 1,226 | 1,194 | 1,567 |
| TOTAL | $1,114,600 | $988,436 | $897,234 | $1,055,509 | $1,341,745 |
| Non-Current Assets | |||||
| PPE Net | 38,703 | 37,679 | 38,865 | 40,012 | 40,350 |
| Investments And Advances | 94,220 | 250,268 | 425,449 | 319,472 | 92,522 |
| Other Non-Current Assets | 44,939 | 44,475 | 42,614 | 34,973 | 35,198 |
| TOTAL | $177,862 | $332,422 | $506,928 | $394,457 | $168,070 |
| Total Assets | $1,292,462 | $1,320,858 | $1,404,162 | $1,449,966 | $1,509,815 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,116 | 3,358 | 4,779 | 4,817 | 4,235 |
| Accrued Expenses | 34,358 | 33,039 | 53,165 | 28,886 | 26,634 |
| Other current liabilities | 300,815 | 299,184 | 320,301 | 15,296 | 15,488 |
| TOTAL | $348,160 | $341,240 | $378,245 | $54,251 | $51,412 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 59,854 | 61,691 | 63,626 | 383,438 | 385,698 |
| TOTAL | $59,854 | $61,691 | $63,626 | $383,438 | $385,698 |
| Total Liabilities | $408,014 | $402,931 | $441,871 | $437,689 | $437,110 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,348 | 122,948 | 122,833 | 122,126 | 121,640 |
| Common Shares | 1,558 | 1,554 | 1,548 | 1,545 | 1,541 |
| Retained earnings | -769,010 | -710,216 | -644,996 | -569,735 | -485,147 |
| Other shareholders' equity | -12,274 | -9,251 | -2,499 | -521 | -368 |
| TOTAL | $884,448 | $917,927 | $962,291 | $1,012,277 | $1,072,705 |
| Total Liabilities And Equity | $1,292,462 | $1,320,858 | $1,404,162 | $1,449,966 | $1,509,815 |